Mobile

Phase III trial of LHRH analog administration during chemotherapy to reduce ovarian failure following chemotherapy in early stage, hormone-receptor negative breast cancer

Mise à jour : Il y a 4 ans
Référence : EUCTR2006-002600-33

Femme Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

The primary objective of this study is to compare the rate of premature ovarian failure at two years following standard adjuvant or neoadjuvant chemotherapy with or without the addition of ovarian suppression with a LHRH analog during chemotherapy in premenopausal women with early stage, hormone-receptor negative breast cancer.

Critère d'inclusion

  • Premenopausal women, Early Stage I, II or IIIA, ER-/ PR- Breast Cancer

Liens